SII to acquire 20 per cent stake in IntegriMedical
Vaccines manufacturer Serum Institute of India (SII) on Friday said it is acquiring 20 per cent stake in IntegriMedical, to advance needle-free injection system technology. IntegriMedical has developed a US patented needle-free Injection System (N-FIS) that utilises high-velocity jet stream using
United States Sarvesh Mutha Adar Poonawalla Serum Institute Of India Device Single Audit Program Central Drugs Standard Control Organisation
Source: dailypioneer.com